Word

NALMEFENE HCL

Status

Pending

Status Code

731

Status Date

Tuesday, March 12, 2024

Serial Number

97306650

Mark Type

3000

Filing Date

Thursday, March 10, 2022

Published for Opposition

Tuesday, January 17, 2023

Trademark Owner History

Purdue Pharma L.P. - Owner At Publication

Classifications

5 Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Syringes filled with opioid antagonists; Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectors filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectable pharmaceuticals, namely, opioid antagonists

The mark consists of the words Nalmefene HCl beneath 5 small squares and three horizontal lines that transition from solid to decreasing shading.
"NALMEFENE HCL"

Trademark Events

Mar 13, 2024

Notice Of Approval Of Extension Request E-Mailed

Mar 12, 2024

Sou Extension 2 Granted

Mar 12, 2024

Sou Extension 2 Filed

Mar 12, 2024

Sou Teas Extension Received

Sep 12, 2023

Notice Of Approval Of Extension Request E-Mailed

Sep 8, 2023

Sou Extension 1 Granted

Sep 8, 2023

Sou Extension 1 Filed

Sep 8, 2023

Sou Teas Extension Received

Mar 14, 2023

Noa E-Mailed - Sou Required From Applicant

Jan 17, 2023

Official Gazette Publication Confirmation E-Mailed

Jan 17, 2023

Published For Opposition

Dec 28, 2022

Notification Of Notice Of Publication E-Mailed

Dec 15, 2022

Approved For Pub - Principal Register

Dec 10, 2022

Teas/Email Correspondence Entered

Dec 9, 2022

Correspondence Received In Law Office

Dec 9, 2022

Teas Response To Office Action Received

Jun 14, 2022

Notification Of Priority Action E-Mailed

Jun 14, 2022

Priority Action E-Mailed

Jun 14, 2022

Priority Action Written

Jun 7, 2022

Assigned To Examiner

Mar 17, 2022

Notice Of Design Search Code E-Mailed

Mar 16, 2022

New Application Office Supplied Data Entered

Mar 14, 2022

New Application Entered